TERT and acute myeloid leukemia: TERT 1062A> T (rs35719940) that has been identified as a susceptibility mutation in an Egyptian AML population, was found in 10/249 patients (4%) and in 22 of 806 healthy control (2.7%), (OR = 1.47, 95% CI 0.68–3.14, p = 0.21).